148 related articles for article (PubMed ID: 18393860)
1. Melanin-concentrating hormone receptor 1 antagonists: a new perspective for the pharmacologic treatment of obesity.
Rivera G; Bocanegra-García V; Galiano S; Cirauqui N; Ceras J; Pérez S; Aldana I; Monge A
Curr Med Chem; 2008; 15(10):1025-43. PubMed ID: 18393860
[TBL] [Abstract][Full Text] [Related]
2. Antiobesity effects of melanin-concentrating hormone receptor 1 (MCH-R1) antagonists.
Cheon HG
Handb Exp Pharmacol; 2012; (209):383-403. PubMed ID: 22249825
[TBL] [Abstract][Full Text] [Related]
3. Promising strategies for obesity pharmacotherapy: melanocortin-4 (MC-4) receptor agonists and melanin concentrating hormone (MCH) receptor-1 antagonists.
Jeon MK; Cheon HG
Curr Top Med Chem; 2009; 9(6):504-38. PubMed ID: 19689363
[TBL] [Abstract][Full Text] [Related]
4. Melanin-concentrating hormone receptor-1 antagonists as antiobesity therapeutics: current status.
Kowalski TJ; Sasikumar T
BioDrugs; 2007; 21(5):311-21. PubMed ID: 17896837
[TBL] [Abstract][Full Text] [Related]
5. Recent patents on novel MCH1 receptor antagonists as potential anti-obesity drugs.
Szalai KK; Beke G; Éles J; Kitka T; Kovács P; Nagy J; Farkas S; Boros A
Recent Pat CNS Drug Discov; 2014; 9(2):122-40. PubMed ID: 24924101
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic potential of melanin-concentrating hormone-1 receptor antagonists for the treatment of obesity.
Kowalski TJ; McBriar MD
Expert Opin Investig Drugs; 2004 Sep; 13(9):1113-22. PubMed ID: 15330743
[TBL] [Abstract][Full Text] [Related]
7. Discovery of novel, orally available benzimidazoles as melanin concentrating hormone receptor 1 (MCHR1) antagonists.
Sasmal PK; Sasmal S; Rao PT; Venkatesham B; Roshaiah M; Abbineni C; Khanna I; Jadhav VP; Suresh J; Talwar R; Muzeeb S; Receveur JM; Frimurer TM; Rist Ø; Elster L; Högberg T
Bioorg Med Chem Lett; 2010 Sep; 20(18):5443-8. PubMed ID: 20724156
[TBL] [Abstract][Full Text] [Related]
8. Discovery of bicycloalkyl urea melanin concentrating hormone receptor antagonists: orally efficacious antiobesity therapeutics.
McBriar MD; Guzik H; Xu R; Paruchova J; Li S; Palani A; Clader JW; Greenlee WJ; Hawes BE; Kowalski TJ; O'Neill K; Spar B; Weig B
J Med Chem; 2005 Apr; 48(7):2274-7. PubMed ID: 15801820
[TBL] [Abstract][Full Text] [Related]
9. Discovery of orally efficacious melanin-concentrating hormone receptor-1 antagonists as antiobesity agents. Synthesis, SAR, and biological evaluation of bicyclo[3.1.0]hexyl ureas.
McBriar MD; Guzik H; Shapiro S; Paruchova J; Xu R; Palani A; Clader JW; Cox K; Greenlee WJ; Hawes BE; Kowalski TJ; O'neill K; Spar BD; Weig B; Weston DJ; Farley C; Cook J
J Med Chem; 2006 Apr; 49(7):2294-310. PubMed ID: 16570926
[TBL] [Abstract][Full Text] [Related]
10. Solid-phase synthesis and structure-activity relationships of novel biarylethers as melanin-concentrating hormone receptor-1 antagonists.
Ma V; Bannon AW; Baumgartner J; Hale C; Hsieh F; Hulme C; Rorrer K; Salon J; van Staden C; Tempest P
Bioorg Med Chem Lett; 2006 Oct; 16(19):5066-72. PubMed ID: 16887348
[TBL] [Abstract][Full Text] [Related]
11. Identification of a new small molecule chemotype of Melanin Concentrating Hormone Receptor-1 antagonists using pharmacophore-based virtual screening.
Helal MA; Chittiboyina AG; Avery MA
Bioorg Med Chem Lett; 2019 Dec; 29(24):126741. PubMed ID: 31678007
[TBL] [Abstract][Full Text] [Related]
12. Fighting obesity with a sugar-based library: discovery of novel MCH-1R antagonists by a new computational-VAST approach for exploration of GPCR binding sites.
Heifetz A; Barker O; Verquin G; Wimmer N; Meutermans W; Pal S; Law RJ; Whittaker M
J Chem Inf Model; 2013 May; 53(5):1084-99. PubMed ID: 23590178
[TBL] [Abstract][Full Text] [Related]
13. Discovery of novel diarylketoxime derivatives as selective and orally active melanin-concentrating hormone 1 receptor antagonists.
Suzuki T; Kameda M; Ando M; Miyazoe H; Sekino E; Ito S; Masutani K; Kamijo K; Takezawa A; Moriya M; Ito M; Ito J; Nakase K; Matsushita H; Ishihara A; Takenaga N; Tokita S; Kanatani A; Sato N; Fukami T
Bioorg Med Chem Lett; 2009 Sep; 19(18):5339-45. PubMed ID: 19683441
[TBL] [Abstract][Full Text] [Related]
14. Discovery of 1,3-disubstituted-1H-pyrrole derivatives as potent melanin-concentrating hormone receptor 1 (MCH-R1) antagonists.
Berglund S; Egner BJ; Gradén H; Gradén J; Morgan DG; Inghardt T; Giordanetto F
Bioorg Med Chem Lett; 2008 Sep; 18(17):4859-63. PubMed ID: 18682323
[TBL] [Abstract][Full Text] [Related]
15. New amide derivatives as melanin-concentrating hormone receptor 1 antagonists for the treatment of obesity.
Cirauqui N; Ceras J; Galiano S; Pérez-Silanes S; Juanenea L; Rivera G; Aldana I; Monge A
Arzneimittelforschung; 2008; 58(11):585-91. PubMed ID: 19137910
[TBL] [Abstract][Full Text] [Related]
16. Anti-obesity effects of small molecule melanin-concentrating hormone receptor 1 (MCHR1) antagonists.
Luthin DR
Life Sci; 2007 Jul; 81(6):423-40. PubMed ID: 17655875
[TBL] [Abstract][Full Text] [Related]
17. Melanin concentrating hormone receptor 1 (MCHR1) antagonists-Still a viable approach for obesity treatment?
Högberg T; Frimurer TM; Sasmal PK
Bioorg Med Chem Lett; 2012 Oct; 22(19):6039-47. PubMed ID: 22954736
[TBL] [Abstract][Full Text] [Related]
18. Obesity: Current Treatment and Future Horizons.
Omran Z
Mini Rev Med Chem; 2017; 17(1):51-61. PubMed ID: 27320641
[TBL] [Abstract][Full Text] [Related]
19. Melanin-concentrating hormone-1 receptor antagonists for the treatment of obesity.
Handlon AL; Zhou H
J Med Chem; 2006 Jul; 49(14):4017-22. PubMed ID: 16821761
[No Abstract] [Full Text] [Related]
20. Recent progress in the discovery of melanin-concentrating hormone 1-receptor antagonists.
Johansson A
Expert Opin Ther Pat; 2011 Jun; 21(6):905-25. PubMed ID: 21492020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
